These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 35316551)

  • 1. A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders.
    Seirafianpour F; Pourriyahi H; Gholizadeh Mesgarha M; Pour Mohammad A; Shaka Z; Goodarzi A
    Dermatol Ther; 2022 Jun; 35(6):e15461. PubMed ID: 35316551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the adverse events of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, and Johnson and Johnson COVID-19 vaccination on Guillain-Barré Syndrome.
    Meo SA; Shaikh N; Abukhalaf FA; Meo AS
    Sci Rep; 2024 Aug; 14(1):18767. PubMed ID: 39138276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous reactions after COVID-19 vaccination in Turkey: A multicenter study.
    Cebeci Kahraman F; Savaş Erdoğan S; Aktaş ND; Albayrak H; Türkmen D; Borlu M; Arıca DA; Demirbaş A; Akbayrak A; Polat Ekinci A; Gökçek GE; Çelik HA; Taşolar MK; An İ; Temiz SA; Hazinedar E; Ayhan E; Hızlı P; Solak EÖ; Kılıç A; Yılmaz E
    J Cosmet Dermatol; 2022 Sep; 21(9):3692-3703. PubMed ID: 35780311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study.
    McMahon DE; Kovarik CL; Damsky W; Rosenbach M; Lipoff JB; Tyagi A; Chamberlin G; Fathy R; Nazarian RM; Desai SR; Lim HW; Thiers BH; Hruza GJ; French LE; Blumenthal K; Fox LP; Freeman EE
    J Am Acad Dermatol; 2022 Jan; 86(1):113-121. PubMed ID: 34517079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.
    McMahon DE; Amerson E; Rosenbach M; Lipoff JB; Moustafa D; Tyagi A; Desai SR; French LE; Lim HW; Thiers BH; Hruza GJ; Blumenthal KG; Fox LP; Freeman EE
    J Am Acad Dermatol; 2021 Jul; 85(1):46-55. PubMed ID: 33838206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological characteristics of cutaneous complications following COVID-19 vaccination: A case series.
    Diab R; Rakhshan A; Salarinejad S; Pourani MR; Ansar P; Abdollahimajd F
    J Cosmet Dermatol; 2024 Mar; 23(3):725-730. PubMed ID: 37899662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases.
    Petruzzi M; Galleggiante S; Messina S; Della Vella F
    BMC Oral Health; 2022 Mar; 22(1):90. PubMed ID: 35331228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant Severe Psoriasis and Bullous Pemphigoid Induced by COVID-19.
    Martora F; Battista T; Fabbrocini G; Megna M
    Trop Med Infect Dis; 2023 Feb; 8(2):. PubMed ID: 36828523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Side effects associated with homogenous and heterogenous doses of Oxford-AstraZeneca vaccine among adults in Bangladesh: an observational study.
    Sharif N; Opu RR; Saha T; Khan A; Aljohani A; Alsuwat MA; García CO; Vázquez AA; Alzahrani KJ; Miramontes-González JP; Dey SK
    Sci Rep; 2024 Oct; 14(1):23794. PubMed ID: 39394252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous adverse reactions of COVID-19 vaccines: A systematic review.
    Qaderi K; Golezar MH; Mardani A; Mallah MA; Moradi B; Kavoussi H; Shamsabadi A; Golezar S
    Dermatol Ther; 2022 May; 35(5):e15391. PubMed ID: 35194894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of Mucocutaneous Reactions to COVID-19 Vaccination: A Report from a Web-Based Study from India.
    Sil A; Jakhar D; Das A; Jagadeesan S; Aradhya SS
    Indian J Dermatol; 2022; 67(2):115-120. PubMed ID: 36092222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks.
    Esmaeilzadeh A; Maleki AJ; Moradi A; Siahmansouri A; Yavari MJ; Karami P; Elahi R
    Expert Rev Vaccines; 2022 Oct; 21(10):1377-1394. PubMed ID: 35986451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous adverse events following COVID-19 vaccination: A case series of 30 Japanese patients and a review of 93 Japanese studies.
    Baba A; Yamada K; Kanekura T
    J Dermatol; 2024 Jun; 51(6):827-838. PubMed ID: 38605482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid Inconveniences With Vaccination Against SARS-CoV-2: The Size of the Matter. A Systematic Review.
    Caironi V; Pitoia F; Trimboli P
    Front Endocrinol (Lausanne); 2022; 13():900964. PubMed ID: 35813627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous Complications of mRNA and AZD1222 COVID-19 Vaccines: A Worldwide Review.
    Kroumpouzos G; Paroikaki ME; Yumeen S; Bhargava S; Mylonakis E
    Microorganisms; 2022 Mar; 10(3):. PubMed ID: 35336199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaphylactic and nonanaphylactic reactions to SARS-CoV-2 vaccines: a systematic review and meta-analysis.
    Alhumaid S; Al Mutair A; Al Alawi Z; Rabaan AA; Tirupathi R; Alomari MA; Alshakhes AS; Alshawi AM; Ahmed GY; Almusabeh HM; Alghareeb TT; Alghuwainem AA; Alsulaiman ZA; Alabdulmuhsin MA; AlBuwaidi EA; Dukhi AKB; Mufti HN; Al-Qahtani M; Dhama K; Al-Tawfiq JA; Al-Omari A
    Allergy Asthma Clin Immunol; 2021 Oct; 17(1):109. PubMed ID: 34656181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Unusual Presentation of Erythema Multiforme Following the Administration of Pfizer-BioNTech COVID-19 mRNA Vaccine in a Pediatric Patient.
    Alghamdi Y; Abdulghani F; Huwait HF; Abdulghani M; Samarkandy SJ
    Cureus; 2024 Apr; 16(4):e58450. PubMed ID: 38765345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.